BR9508629A - Composto solvato e hidrato do mesmo processos para o tratamento ou profilaxia de uma infecção viral num ser humano e para a preparação do composto uso de um composto e formulação farmacêutica - Google Patents

Composto solvato e hidrato do mesmo processos para o tratamento ou profilaxia de uma infecção viral num ser humano e para a preparação do composto uso de um composto e formulação farmacêutica

Info

Publication number
BR9508629A
BR9508629A BR9508629A BR9508629A BR9508629A BR 9508629 A BR9508629 A BR 9508629A BR 9508629 A BR9508629 A BR 9508629A BR 9508629 A BR9508629 A BR 9508629A BR 9508629 A BR9508629 A BR 9508629A
Authority
BR
Brazil
Prior art keywords
compound
prophylaxis
solvate
treatment
viral infection
Prior art date
Application number
BR9508629A
Other languages
English (en)
Inventor
Susan Mary Daluge
Jeffrey Douglas Wilson
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of BR9508629A publication Critical patent/BR9508629A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
BR9508629A 1994-08-26 1995-08-25 Composto solvato e hidrato do mesmo processos para o tratamento ou profilaxia de uma infecção viral num ser humano e para a preparação do composto uso de um composto e formulação farmacêutica BR9508629A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9417249A GB9417249D0 (en) 1994-08-26 1994-08-26 A novel salt
PCT/GB1995/002014 WO1996006844A1 (en) 1994-08-26 1995-08-25 4-(2-amino-6-(cyclopropylamino)-9h-purin-9-yl)-2-cyclopentene-1-methanol succinate as antiviral agent

Publications (1)

Publication Number Publication Date
BR9508629A true BR9508629A (pt) 1997-11-25

Family

ID=10760434

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9508629A BR9508629A (pt) 1994-08-26 1995-08-25 Composto solvato e hidrato do mesmo processos para o tratamento ou profilaxia de uma infecção viral num ser humano e para a preparação do composto uso de um composto e formulação farmacêutica

Country Status (23)

Country Link
EP (1) EP0777669B1 (pt)
JP (1) JPH10505593A (pt)
KR (1) KR100376240B1 (pt)
CN (1) CN1051550C (pt)
AT (1) ATE220067T1 (pt)
AU (1) AU702618B2 (pt)
BR (1) BR9508629A (pt)
CA (1) CA2198010C (pt)
DE (1) DE69527294T2 (pt)
DK (1) DK0777669T3 (pt)
ES (1) ES2179110T3 (pt)
FI (1) FI120403B (pt)
GB (1) GB9417249D0 (pt)
HU (1) HU221302B1 (pt)
IL (1) IL115074A (pt)
MX (1) MX9701273A (pt)
NO (1) NO315200B1 (pt)
NZ (1) NZ291862A (pt)
PT (1) PT777669E (pt)
RU (1) RU2145324C1 (pt)
SI (1) SI0777669T1 (pt)
WO (1) WO1996006844A1 (pt)
ZA (1) ZA957166B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY115461A (en) 1995-03-30 2003-06-30 Wellcome Found Synergistic combinations of zidovudine, 1592u89 and 3tc
GB9709945D0 (en) 1997-05-17 1997-07-09 Glaxo Group Ltd A novel salt
BR9809124A (pt) * 1997-05-17 2000-08-01 Glaxo Group Ltd Combinação, formulação, farmacêutica, processo para o tratamento de uma infecção por hiv em um animal, infectado, uso de (-)-(1s, 4r)-4-[2-amino-6-(ciclopropilamino)-9h-purin-9-il)-2-cicl openteno-1-metanol, e, pacote de paciente
AR012702A1 (es) * 1997-05-17 2000-11-08 Glaxo Group Ltd Combinacion de (-)-(1s,4r)-4-[2-amino-6-(ciclopropilamino)-9h-purin-9-il]- 2-ciclopenteno-1-metanol y un inhibidor dee transcriptasa reversa no nucleosidouna formulacion farmaceutica que comprende la combinacion, su uso medico en terapia para tratar la infeccion de vih, y un empaque para el paciente
SK284594B6 (sk) * 1997-11-27 2005-07-01 Lonza Ag Spôsob výroby derivátov aminoalkoholov a ich soli
GB9802472D0 (en) 1998-02-06 1998-04-01 Glaxo Group Ltd Pharmaceutical compositions
GB9903091D0 (en) 1999-02-12 1999-03-31 Glaxo Group Ltd Therapeutic nucleoside compound
US7462733B2 (en) 2001-07-30 2008-12-09 University Of Southern California Preparation and use of α-keto phosphonates
RU2317295C1 (ru) * 2003-10-27 2008-02-20 Мерк Энд Ко., Инк. Соль антагониста ccr-2
EP2305680A3 (en) 2009-09-30 2011-05-18 Aurobindo Pharma Limited Novel salts of (1S,4R)-cis-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol
EP2697238B1 (en) 2011-04-08 2019-03-20 Laurus Labs Limited Solid forms of antiretroviral compounds, process for the preparation and their pharmaceutical composition thereof
US9457028B2 (en) 2013-02-27 2016-10-04 Kyoto University Pharmaceutical composition for use in prevention or treatment of cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3025492A1 (de) * 1980-07-04 1982-02-04 Siemens AG, 1000 Berlin und 8000 München Filterelement fuer die optische nachrichtentechnik
GB8815265D0 (en) * 1988-06-27 1988-08-03 Wellcome Found Therapeutic nucleosides
MY104575A (en) * 1989-12-22 1994-04-30 The Wellcome Foundation Ltd Therapeutic nucleosides.
IL104283A (en) * 1992-12-30 1996-12-05 Agis Ind 1983 Ltd Non-emulsion antiviral topical pharmaceutical composition comprising acyclovir an aqueous gel agent and an alkali oleate

Also Published As

Publication number Publication date
AU702618B2 (en) 1999-02-25
CA2198010C (en) 2006-05-02
WO1996006844A1 (en) 1996-03-07
MX9701273A (es) 1997-05-31
JPH10505593A (ja) 1998-06-02
ATE220067T1 (de) 2002-07-15
DK0777669T3 (da) 2002-10-28
FI970786A (fi) 1997-02-25
DE69527294D1 (en) 2002-08-08
NZ291862A (en) 1998-02-26
CN1156456A (zh) 1997-08-06
KR970705563A (ko) 1997-10-09
EP0777669A1 (en) 1997-06-11
DE69527294T2 (de) 2003-02-13
GB9417249D0 (en) 1994-10-19
ES2179110T3 (es) 2003-01-16
PT777669E (pt) 2002-11-29
CA2198010A1 (en) 1996-03-07
SI0777669T1 (en) 2002-12-31
IL115074A0 (en) 1995-12-08
NO970847L (no) 1997-02-25
ZA957166B (en) 1997-02-25
NO315200B1 (no) 2003-07-28
FI120403B (fi) 2009-10-15
NO970847D0 (no) 1997-02-25
EP0777669B1 (en) 2002-07-03
IL115074A (en) 1998-10-30
HUT77222A (hu) 1998-03-02
RU2145324C1 (ru) 2000-02-10
AU3350995A (en) 1996-03-22
HU221302B1 (en) 2002-09-28
FI970786A0 (fi) 1997-02-25
CN1051550C (zh) 2000-04-19
KR100376240B1 (ko) 2003-06-11

Similar Documents

Publication Publication Date Title
TW371660B (en) Therapeutic nucleosides a purine carbocyclic nucleosides for treatment of HIV and HBV infections
MY117892A (en) Therapeutic compounds
MY107843A (en) Anti-viral compounds.
ES8801303A1 (es) Un procedimiento para preparar una formulacion farmaceutica que contiene un 2'3'-didesoxi-nucleosido.
UA29429C2 (uk) Фармацевтична композиція для лікування вірусних інфекцій, спосіб отримання композиції, спосіб лікування або профілактики віл-інфекції у людини
MD1224B2 (en) Application of nucleoside analogues with 1,3-oxathiolan for treatment of hepatitis B
RU94002475A (ru) Фармацевтическая композиция и ее применение для лечения вирусных инфекций
MY104043A (en) Therapeutic nucleosides.
HUT46336A (en) Process for producing 5-substituted pyrimidine nucleosides and pharmaceutical compositions comprising the same as active ingredient
BR9508629A (pt) Composto solvato e hidrato do mesmo processos para o tratamento ou profilaxia de uma infecção viral num ser humano e para a preparação do composto uso de um composto e formulação farmacêutica
DK326586A (da) Antivirale pyrimidinforbindelser, farmaceutiske kompositioner indeholdende forbindelserne og kompositionernes fremstilling
BRPI9809126B8 (pt) composto,uso e processo para preparação do mesmo,e,formulação farmacêutica
NZ324380A (en) Therapeutic benzimidazole compounds and their use in treatment of virus infections
MY105855A (en) Therapeutic nucleotides.
MY111746A (en) Therapeutic nucleosides.
AU6751794A (en) Extracts of piliostigma thonningii, the use thereof and formulations containing them
MX9401370A (es) Terapia antiviral.
CA2193665A1 (en) Benzimidazole derivatives for the treatment and prophylaxis of virus infections

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal